Cargando…
Resuming anti-TNF therapy after development of miliary tuberculosis in Behcet’s disease-related uveitis: a case report
PURPOSE: There is no consensus concerning restarting anti-tumour necrosis factor (TNF)-α therapy for uveitis after treatment for active tuberculosis (TB). We report a case of Behcet disease (BD) in which treatment with TNF inhibitor was successfully resumed after treatment for miliary TB. CASE REPOR...
Autores principales: | Toriu, Chika, Tsubota, Kinya, Usui, Yoshihiko, Goto, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684474/ https://www.ncbi.nlm.nih.gov/pubmed/38017191 http://dx.doi.org/10.1186/s12348-023-00375-w |
Ejemplares similares
-
Pulmonary and intracranial miliary tuberculosis secondary to Behçet's anti-TNF alfa treatment
por: Sekkat, Asmae, et al.
Publicado: (2020) -
Serum Metabolomic Profiling of Patients with Non-Infectious Uveitis
por: Shimizu, Hiroyuki, et al.
Publicado: (2020) -
Comprehensive miRNA Analysis Using Serum From Patients With Noninfectious Uveitis
por: Asakage, Masaki, et al.
Publicado: (2020) -
Identification of Prognostic Markers in Patients with Primary Vitreoretinal Lymphoma by Clustering Analysis Using Clinical Data
por: Tsubota, Kinya, et al.
Publicado: (2020) -
Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease
por: Sugita, Sunao, et al.
Publicado: (2012)